chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 1 day after receiving Tdap vaccine, I experienced diarrhea, uncontrolled frequent bowel movements, frequent bloody stools, fatigue, etc which lasted continuously for 10 days.  Presently, I am experiencing intermittent diarrhea, uncontrolled frequent bowel movements, frequent bloody stools, fatigue, etc .  This resulted in exacerbation of the colon.
About 10-20 seconds after receiving vaccine I felt faint and the darkness started to close in and I almost passed out.  The back of my tongue became very dry.   I felt better after 10 minutes and never passed out.  They took my vital signs and everything was normal.  I have never been bothered by needles before at all so it was strange.  However I do have a long history of anxiety so it?s possible it was just that.
Narrative:  Pt received his COVID vaccine at 1208. Pt stayed in the COVID vaccine waiting room for 15 minutes for observation per protocol. After leaving the clinic, patient came back around 1230 because he stated: "I am feeling stoned and loopy." Had the patient sit down in the ante room of the Covid vaccine clinic. 1234: While sitting, CNA noticed that pt had a blank stare, unresponsive, and started to lean towards his R side. 1235: clinic nurses and 911 were called. Patient's eyes rolled back and is eased the patient out of the chair onto the floor. Cleared the area around of anything hard or sharp. Pillow placed underneath patient's head. VS taken as follows: 130/75 HR 119 bpm, O2 Sat 99%. While on the floor, pt remained unresponsive to verbal or any noxious stimuli. 1238: Epipen administered on RUE. Pt woke and sat up asking what happened to him. Pt reports: "I forgot to tell you guys that I have history of seizures." Placed pt on O2 at 2lpm via nasal cannula. VS as follows: 130/75 hr 122 BPM, O2 Sat 99%. 1240: Pt had grand mal seizures again for 2 minutes. Placed pt on his L side. Dr. arrived. Pt is monitored with pulse oximetry. HR 119 bpm, O2 sat 99%. 1243: Pt woke up from his seizure and asked what happened. He stood up for about 10 seconds and pt suddenly lost his balance and knelt. 1245: EMS arrived, handoff given. Pt is transported to Medical Center.
rash in face and back; This is a spontaneous report from a contactable consumer (patient herself). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 07Jan2021 14:30 (Batch/Lot Number: Ej1686) as 1st dose, single for COVID-19 immunisation. Medical history included immunoglobulin g4 related disease (IGG4-RD) and rheumatoid arthritis. The patient was not diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported.  The patient previously took rituxan and experienced allergies. The patient experienced rash in face and back on an unspecified date in Jan2021. The outcome of event was recovering.    Information about bat/lot number has been obtained.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. No information about the patient's medical history, concurrent conditions and concomitant medications was reported. On an unknown date, the patient was vaccinated with (wistar ra 27-3) M-M-R II lot # M045393, expiry date: 14-NOV-2018, subcutaneously, for prevention of measles, mumps and rubella. Concomitant therapies included sterile diluent. On an unknown date, the patient's postvaccination serologic testing was negative for an immune response. The outcome of the event was unknown. Causality assessment was not reported.
Right upper arm and erythema, and swelling, and warmth firm to palpation and itchiness. Full ROM with no pain, numbness, nor fever. Advised to use TYLENOL/Ibuprofen as needed, BENADRYL, ice call with worse symptoms.
hives right lower arm, both lower and upper legs; starts in mornings looking like hives, as day progresses turns into  small red bumps slightly raised
pt became tachy to 160's and felt palpitations upon rising from chair after 15min waiting period; ST on monitor, pt denies additional symptoms, afebrile, 100% RA, 16RR, 140's SBP;
Initial report was received 29 September 2011 from a health care professional, who heard about the following report. An unidentified patient had received an injection of FLUZONE HIGH-DOSE (lot number, route, site and date of administration not reported) and an unspecified amount of time later, the patient had a feeling of their throat closing and had to be taken to the hospital for treatment (treatments unspecified). According to the reporter, this patient had received FLUZONE HIGH-DOSE at another facility from another person. Outcome was not reported. No additional information was provided at the time of the report. The reporter for this case is the same as for case number 2011-09435.
Swollen Left thigh with redness around site of injection. Rx BENADRYL swap 2 tsp q 6 hrs. PRN.
raised bumps under both arms; Cough; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration, in the right arm on 11Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 Immunisation. Medical history included asthma, sinus issues and sore throat. Prior to the vaccination, the patient was not diagnosed with COVID-19 and tested negative for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included doxycycline (Manufacturer unknown) for an unspecified indication. The patient was allergic to amoxicillin. On 12Mar2021, the patient experienced raised bumps under both arms. It was reported that the bumps looked like hives but they're not itchy for the patient. It was reported that these bumps started to appear the day after the shot. On an unspecified date in Mar2021, the patient had cough but unsure if it's from my sinus cold or from the vaccine. The patient did not receive any treatment for the events. The clinical outcome of the raised bumps under both arms was not recovered and the outcome of cough was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse and a healthcare worker, concerning a 62 year old male patient who on an unknown date was vaccinated with a dose of PNEUMOVAX 23 (lot # 654977/0888F), and developed cellulitis. The patient was hospitalized for treatment and evaluation (details not specified). At the time of this report, the outcome of the event was  unknown. This is one of several reports received from the same source (WAES #0709USA02720 and 0709USA03917)
No symptoms were reported; patient was inadvertently administered one dose of VAQTA which was expired; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about patient's pertinent concurrent conditions, medical history, concomitant medications and previous drug reactions and allergies were not provided.  On 12-MAR-2020, the patient was inadvertently vaccinated with an expired hepatitis a vaccine, inactivated (VAQTA) strength 50/1.0 units per milliliter (U/ml), 1 dose as prophylaxis (vaccination scheme frequency, route and anatomical location of vaccination were not reported; lot number S001360, and expiration date reported 06-MAR-2020) (expired product administered). The product had not undergone any temperature excursions and no symptoms were reported for the patient.
Case number PHEH2014US002948 is an initial spontaneous report received from a nurse on 10 Feb 2014. This report refers to a 12-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with 0.5 ml dose of MENVEO, (batch number: A13013, expiry date: Sep 2014) intramuscularly on 07 Feb 2014. On the same day, post vaccination, she experienced swelling, pain, hardness and redness at the injection site. Outcome of the events was reported as condition unchanged at the time of this report. Seriousness and causality of the events was not reported.
Patient stated his HCP recommended Paxlovid; Patient stated his HCP recommended Paxlovid; got the Moderna bivalent booster 2 days ago noting that his other vaccines were Pfizer; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 11Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 11Oct2022, outcome "unknown", described as "got the Moderna bivalent booster 2 days ago noting that his other vaccines were Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Patient stated his HCP recommended Paxlovid".  Clinical course: Patient stated he just got the Moderna bivalent booster 2 days ago noting that other vaccines were Pfizer. Patient stated his HCP recommended Paxlovid. Patient wanted to know if Paxlovid will harm the immune response to the booster.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
lymphadenopathy on left Axilla; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Complex regional pain syndrome" (ongoing), notes: Complex regional pain syndrome on the right arm. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "not recovered", described as "lymphadenopathy on left Axilla". The event "lymphadenopathy on left axilla" was evaluated at the physician office visit.  The lot number for bnt162b2 was not provided and will be requested during follow up.  Additional information: Caller was an LPN calling on behalf of her own side effect after receiving the second dose of Pfizer BioNtech vaccine. First dose was administered Aug202 and second dose of vaccine was given some time after. After the second dose of Pfizer BioNtech Covid vaccine she developed lymphadenopathy on left axilla that has not yet subsided and was still ongoing even after 6 months. It was about 2-3 centimetre, and it was pretty large however it does not cause any pain or discomfort. She was due for her booster dose, and she would like to know if she could receive the booster with an ongoing lymphadenopathy and if there was any information on how long she needs to wait before this subsides. She had read somewhere that some cases, had an ongoing lymphadenopathy for up to 43 weeks post vaccination. She stated that after visiting the oncologist, the oncologist opted that she should have a biopsy on the lymph node and to delay receiving the booster dose for another 3-4 months and she would like to know if there was any information regarding getting the booster dose at any time aside from the recommended 6 months interval and what would be the level of immunity or antibody level. She also stated that the oncologist advised her not to get the booster dose on the left arm however she was suffering from complex regional pain syndrome on the right arm. She would like to know if he could receive the vaccine in other sites aside from her arms, though she was worried if she injects on her leg it would affect her groin lymph node. She would like to know what her antibody level would be if she delays receiving the booster dose for 3-4 months, she would like to know if she would still be being protected. She would like to know if the Covid vaccines come in prefilled syringes. She would like to know what were the blood tests that she could do to determine her antibody level of protection as there was no data regarding her case about receiving the Pfizer BioNtech Booster dose at a longer interval. She would like to know if there was any information at all regarding administration of vaccine to someone with underlying complex regional pain syndrome.
Information has been received from a licensed practical nurse referring to a patient of unknown age and gender. On 27-APR-2015 the patient was vaccinated with an expired dose of PROQUAD (lot number reported as J004173, expiration date 08-OCT-2014, 0.5 ml, subcutaneous). No adverse effects were reported. Additional information has been requested.
Vaccine frozen rather than refrigerated. Dose administered. Offered revaccination. May revaccinate
Patient developed prodrome of herpes zoster on the initial date noted, the next day developed typical lesions of herpes zoster and saw me, was placed on Valtrex and when seen yesterday, 2/23/2021 the herpes zoster located in T11-12 distribution was markedly improved and patient's symptoms of pain and burning were markedly improved.
8/27 day after a small area inside on mouth like a cold sore noted,   One week later my whole upper lip on inside is a sore, blister . Never had a cold sore like this, inside of mouth . Swollen and painful.
Patient developed severe pain right thigh, unable to bear weight. Fever 101 degrees Thigh tender to touch
Approximately 1 month (on 7/5/2021)following 2nd COVID-19 vaccination, patient developed acute focal myositis of left arm--swelling occurred in left forearm (proximal) but patient reported "soreness" along L/arm and forearm. Patient had significant elevation of creatine kinase enzyme. Edema and soreness have resolved and creatinine kinase is closer to normal by 7/9/2021.
fourth dose at the age of 16; This spontaneous report was received from a mother concerning her 16-year-old (currently 22 year old) son. There was no information about the patient's medical history, concurrent conditions or concomitant medication.      At the age of 14 year old, approximately in 2012 the patient was vaccinated with a first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL), the second dose approximately in 2013 at the age of 15 received the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL), and the fourth dose of  quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) at the age of 16, approximately in 2014  for prophylaxis (doses, routes of administration, lot numbers and expiration dates were not reported).  The mother want to know if the patient need a booster of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). The reporter confirmed the consumer received 4 doses all together.
37 year old female with familial cardiomyopathy who received pneumococcal vaccination on 8/17/07 at her primary care office. Several hours later, pt developed swelling, redness, fever and tenderness. The next day pt developed shortness of breath and chest pain. She presented to the ED and was admitted to critical care requiring dobutamine and empiric IV tx for the cellulitis/pneumococcal vaccination reaction. Cardiology determined decompensation related to the Pneumovax reaction.9/7/07-records received for DOS 8/19-8/24/07-DC DX: Cellulitis of left upper arm after Pneumovax injection. Hypotension likely a combination of medications and secondary to reaction to Pneumovax. Acute renal failure (resolved). Left ventricular organized thrombus. Secondary DC DX: recent diagnosis of severe dialted cardiomyopathy, thought to be familial cardiomyopathy. Attention deficit disorder previously on Ritalin. History of nonsustained ventricular tachycardia. Migraine headaces.Admitted with syncopal episode and hypotension. Fever and chills, pain, swelling and warmth to the arm where vaccine was administered
This is ongoing, still running tests, but it is appearing to be Parsonage-Turner Syndrome.  I Had a herniated disc, but that was a side issue. I started having back/shoulder pain about two and a half weeks later, woke up at 3:00am in excruciating pain.  Went to the emergency room the next day, we were out of town. Drove home,  went to chiropractor,  GP Doctor, had an MRI, surgery for herniated disc, but symptoms keep escalating.  Have lost all use of my right hand and arm, absolute no nerve ability to use my hand, extreme weakness right   arm, extreme and ongoing pain.
Menveo was administered instead of Men B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a adolescent female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA791A, expiry date 03-SEP-2024) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong vaccine administered (Verbatim: Menveo was administered instead of Men B). The outcome of the wrong vaccine administered was unknown.   Additional Information: GSK receipt date: 08-AUG-2023 Certified medical assistant (CMA) stated Menveo was administered instead of Men B (month or 2 ago), which led to Wrong vaccine administered. The vaccine administration facility is the same as primary reporter. The reporter consented to follow up via postal.
Adverse event - vial expired 4-1-2022 per moderna lookup; was removed from freezer on 3-24-2022; was labeled by staff for expiring 30 days past removal from freezer, but per moderna lookup tool, expired 4-1-2022. Immunization was given approximately 12 hours past midnight cutoff for expiration. This was the patient's fourth dose, given over 4 months past the first booster dosage. Patient experienced no physical adverse effects at time of injection.
10-5-14 1:00 pm face swelling esp eyelids/under eyes. 10-6-14 8:00 am itchy face. 10-7-14 8:00 am itchy face, sore throat, sl. tachycardia took 2 BENADRYL at noon OTC; states symptoms have decreased at this time.
Wk long course of symptoms began 24 hrs after immunization on Monday. Tuesday - Thursday- Flu; Sunday - Tuesday - Hives across body; Thursday/Friday - Sm cold.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 18-MAY-2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 04-AUG-2014, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
So the second one I had pin point red spots mainly on my stomach but also on other parts of my body, also some blood blisters. They started the day after the vaccine and they still continued, they slowed down but they were very steady and regularly for like ten weeks after the vaccine and now have seemed to slow down. I never had anything like that before in my life. I went to the ER and followed up with my hematologist.
Three red raised welts on R upper arm/lateral deltoid area. No distal erythema, deformity, edema, clubbing, or cyanosis in the R UE.
fever; chills; aching; vomiting; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 15:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications were not reported. The patient has known allergies to tree nuts. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Mar2021 at 15:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation and also received sulfa drugs and was allergic to it.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 07Apr2021 at 04:30, the patient experienced fever, chills, aching and vomiting. the events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, chills, aching and vomiting were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Client woke up at 8:30 pm hysterical, rigid and jerky movements of limbs and head, turning also. She was very distressed. This lasted approximately 45minutes. She was given Tylenol and settled back to sleep around 10 pm. There was no fever.
ON FRIDAY 12/3/2021 MY CHILD RECEIVED HIS SECOND DOSE OF COVID19 VACCINE AT 5:46PM. DEVELOPED AN URTICARIAL RASH 30 MINUTES AFTER INJECTION STARTING ON VACCINE SITE AND CHIN, LATER COVERING MOST OF HIS BODY. TOOK MY CHILD TO THE EMERGENCY ROOM AT ALMOST MIDNIGHT AND DISCHARGED HOME AT 2:30AM.  SINCE THE URTICARIA IS STILL COVERING MOST OF HIS BODY, I TOOK HIM TO HIS PEDIATRICIAN AL 8AM TODAY, SATURDAY 12/4/2021. GIVEN NEW MEDICATION BUT HE IS STILL COMPLAINING OF ITCHING ALL OVER.